Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fujian Huitian Biological Pharmacy is a Chinese pharmaceutical manufacturer focused on active pharmaceutical ingredients, traditional Chinese medicines, and finished-dose western medicines. The company traces its roots to the former Sanming Pharmaceutical Factory of Fujian Province and was founded in 1969. Publicly available descriptions portray Huitian as a comprehensive commercial-stage pharma business with production capabilities spanning chemical synthesis APIs, antibiotic raw materials, injections, tablets, capsules, and botanical extraction. Rather than a venture-stage biotech with a disclosed innovative clinical pipeline, Huitian appears to operate primarily as a manufacturing and commercial pharmaceutical company serving domestic and export markets. Available source material suggests strengths in industrial-scale pharmaceutical production rather than novel target-based drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huitian.